Tag Archives: ABBV

Top 10 Blue Chip Stocks To Buy Right Now

Stocks inched upwardFriday after remarks by Federal Reserve Chair Janet Yellen pointed to a rate hike later this month.

The Dow andS&P 500 posted fractionalgains.The blue chips barelyfinishedhigher on the day, up 3 points and staying above 21,000, ending at 21,005.71.

Climbing 0.2% was the Nasdaq composite, to 5870.75.

At our meeting later this month, the committee will evaluate whether employment and inflation are continuing to evolve in line with our expectations, in which case a further adjustment of the federal funds rate would likely be appropriate, Yellen said in a 1 p.m. ET speech at the Executives Club of Chicago.

While Yellen couched her remark in conditional terms that depend on economic data, she preceded it by citinga job market that has been strengthening and inflation that has been rising toward our target of 2% annually.

Top 10 Blue Chip Stocks To Buy Right Now: Banner Corporation(BANR)

Advisors’ Opinion:

  • [By Ben Levisohn]

    The twenty stocks in Worth’s basket are: Ameriprise Financial (AMP) Bank of America, Banner (BANR), Citigroup, Citizens Financial Group (CFG), East West Bancorp (EWBC), First NBC Bank Holding (FNBC), HFF (HF), KeyCorp(KEY), Legacy Texas Financial Group (LTXB), Lincoln National (LNC), Morgan Stanley, Old National Bancorp (ONB), PacWest Bancorp (PACW), PNC Financial Services Group (PNC), Principal Financial Group (PFG), Stifel Financial (SF), SVB Financial Group (SIVB), TCF Financial (TCB), and Wells Fargo.

Top 10 Blue Chip Stocks To Buy Right Now: Cooper Tire & Rubber Company(CTB)

Advisors’ Opinion:

  • [By Matt Hogan]

    Finbox.io fair value data (as of January 4) shows that there are only five US manufacturing stocks that have 25% or more margin of safety: Vera Bradley, Inc. (NASDAQ: VRA), Cooper Tire & Rubber Co (NYSE: CTB), Farmer Brothers Co. (NASDAQ: FARM), Allergan plc Ordinary Shares (NYSE: AGN) and Motorcar Parts of America, Inc. (NASDAQ: MPAA).

Top 10 Blue Chip Stocks To Buy Right Now: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By Keith Speights]

    Smart investors will be ready to take advantage of a market pullback, whenever it comes and offers discount prices on great stocks. Three drug stocks appear to be excellent choices to buy on a dip: AbbVie (NYSE:ABBV), Allergan (NYSE:AGN), and Celgene (NASDAQ:CELG). Here’s why.

  • [By WWW.MONEYSHOW.COM]

    AbbVie (ABBV) reported third quarter 2016 net sales increased a healthy 8% to $6.4 billion with net income increasing 29% to $1.6 billion and EPS increasing 31% to $.97.

  • [By George Budwell]

    Keeping this theme in mind, I think the Dividend Aristocrats AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Medtronic plc (NYSE:MDT) are three outstanding stocks to steady any portfolio during these uncertain times. Here’s why.

  • [By George Budwell]

    If you’ve been following this stock for any length of time, you’re probably painfully aware that Gilead’s hep C franchise sank like a stone last year. The short version of the story is that the biotech’s super-aggressive pricing strategy for Sovaldi and Harvoni sowed discontent among payers, leading to a pricing war once rival drugs like AbbVie’s (NYSE:ABBV) Viekira Pak hit the market.

Top 10 Blue Chip Stocks To Buy Right Now: Raytheon Company(RTN)

Advisors’ Opinion:

  • [By Money Morning News Team]

    Not all defense firms are doing well in 2016. But Raytheon Co. (NYSE: RTN) is on our list ofbest tech stocksto watch. Not only does this defense giant have hundreds of millions in current missile systems contracts with the U.S. government, but it is also on the forefront of one of the world’s most pressing issues – cybersecurity.

  • [By Dustin Parrett]

    Two of Keith’s favorite Unstoppable Trend stocks are Raytheon Co. (NYSE: RTN) and Becton, Dickinson and Co. (NYSE: BDX). RTN and BDX are leaders in the Unstoppable Trends of defense and demographics, respectively.

  • [By Money Morning News Team]

    If you’re looking for one of thebest investments today, it’s hard to beat Raytheon Co. (NYSE: RTN). It doesn’t matter if the market is up or down, defense spending continues to increase. In the past year, global annual defense spending hit $1.6 trillion, and this is considered to be an industry that is likely to continue to grow for the foreseeable future.

  • [By WWW.THESTREET.COM]

    Raytheon (RTN)  is the third-largest defense contractor in the U.S. and the largest missile maker in the world. The company’s engineering expertise continues to be coveted by America’s top brass and allies around the world.

  • [By Money Morning News Team]

    Raytheon Co. (NYSE: RTN) deploys its expertise in defense systems, government electronics, and information technology.

    RTN’s biggest and most profitable sectors are Integrated Defense Systems (IDS) and Missile Systems (MS).

Top 10 Blue Chip Stocks To Buy Right Now: AirMedia Group Inc(AMCN)

Advisors’ Opinion:

  • [By Paul Ausick]

    AirMedia Group Inc. (NASDAQ: AMCN) posted a 52-week low of $1.04 after closing down 23% on Wednesday at $1.35. The 52-week high is $3.30. Volume was about 4 million, nearly 20 times the daily average of around 230,000 million shares. The Chinese outdoor advertising company said yesterday that it is terminating a potential go-private transaction.

Top 10 Blue Chip Stocks To Buy Right Now: Caladrius Biosciences, Inc.(CLBS)

Advisors’ Opinion:

  • [By Chris Lange]

    Caladrius Biosciences Inc. (NASDAQ: CLBS) watchedits shares soar on Thursday after the company announced a private placement offering. In terms of the specifics, the company entered into securities purchase agreements with several accredited investors for the sale of 4,449,153 shares of its common stock in private placements of $21 million.

  • [By Lisa Levin]

    Caladrius Biosciences Inc (NASDAQ: CLBS) shares shot up 14 percent to $5.83 after the company posted upbeat Q4 results.

    Shares of Norsat International Inc (USA) (NYSE: NSAT) got a boost, shooting up 22 percent to $9.85 after the company reported the receipt of new indication of interest by Privet Fund Management LLP at $10.25 per share.

  • [By Lisa Levin] Related Chardan Analyst Suggests An AveXis-Ionis Pair Trade Why The Biogen-Ionis News Is A Boon For AveXis AveXis' (AVXS) CEO Sean Nolan on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related CLBS Earnings Scheduled For March 17, 2017 15 Biggest Mid-Day Gainers For Thursday Caladrius Biosciences beats by $0.07, beats on revenue (Seeking Alpha) Gainers
    Caladrius Biosciences Inc (NASDAQ: CLBS) shares rose 20.2 percent to $6.13 in pre-market trading after the company reported a narrower-than-expected quarterly loss.
    Arbutus Biopharma Corp (NASDAQ: ABUS) rose 12.3 percent to $3.20 in pre-market trading after the company disclosed that it has licensed LNP delivery technology to Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) for use in single messenger RNA product candidate.
    AveXis Inc (NASDAQ: AVXS) rose 12.2 percent to $81.66 in pre-market trading after the company reported topline data from Phase 1 trial of AVXS-101.
    TOP SHIPS Inc (NASDAQ: TOPS) shares rose 10.5 percent to $2.43 in pre-market trading after surging 109.52 percent on Thursday.
    ChipMOS TECHNOLOGIES INC. (NASDAQ: IMOS) rose 9.8 percent to $17.45 in pre-market trading after declining 0.44 percent on Thursday.
    Sino-Global Shipping America, Ltd. (NASDAQ: SINO) rose 8.3 percent to $3.38 in pre-market trading after climbing 23.81 percent on Thursday.
    Diana Containerships Inc (NASDAQ: DCIX) rose 7.6 percent to $2.99 in pre-market trading after surging 12.55 percent on Thursday.
    Steel Dynamics, Inc. (NASDAQ: STLD) rose 5.2 percent to $37.25 in pre-market trading. Steel Dynamics expects Q1 earnings of $0.77 to $0.81 per diluted share. The company also declared a quarterly cash dividend of $0.1550 per common share.
    Adobe Systems Incorporated (NASDAQ: ADBE)

Top 10 Blue Chip Stocks To Buy Right Now: CNX Coal Resources LP(CNXC)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Well, the time to start buying would have been last February–when everything started rallying. Since February 11, 2016, shares of Alliance Resource Partners (ARLP) have doubled, while Cloud Peak Energy (CLD) and CNX Coal Resources (CNXC) have tripled. Of course, Peabody Energy was fast approaching bankruptcy then, so missed out on that amazing run.

Top 10 Blue Chip Stocks To Buy Right Now: Dermira, Inc.(DERM)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Current market dynamics, particularly in the SMID biotech universe, provide a plethora of opportunities for the company to augment the breadth and depth its pipeline in its core therapeutic areas, including neurology, ophthalmology and dermatology, where innovation is rife and where consolidation of some of the smaller players in the space is likely, in our view. Stocks in our SMID coverage universe that could potentially constitute future acquisition targets forAllergan include Aclaris Therapeutics (ACRS) and Dermira (DERM) (both have mid- to late-stage dermatology assets in development). We note with interest the collaboration with Heptares announced yesterday evening for the development of several M1, M4 and dual M1/M4 agonists in development for a variety of neurological diseases, including Alzheimers disease. Notwithstanding this above, larger scale transactions of course cannot be ruled out, and we note todays market commentary (Fox Business) regarding the potential sale of Valeant Pharmaceuticals International’s (VRX) Bausch & Lomb unit. It is reasonable to assume thatAllergan could be a bidder for this asset, given the companys presence in ophthalmology, as well as CEO Brent Saunders familiarity with the asset (he was the CEO prior to its sale toValeant in 2013 for $8.7bn). At the time of its sale to Valeant, B&L was generating c.$3bn in revenues and growing at a double-digit rate. Current sales of the asset are unclear due to the reporting structure of Valeant, as well as concerns regarding the companys operating/ pricing strategy.

Top 10 Blue Chip Stocks To Buy Right Now: Check Point Software Technologies Ltd.(CHKP)

Advisors’ Opinion:

  • [By Harsh Chauhan]

    But is it a good idea to buy FireEye based on this one incident, despite its huge losses, or should investors look at Check Point Software Technologies(NASDAQ:CHKP), given its focus on growing its bottom line? Let’s find out.

  • [By WWW.THESTREET.COM]

    Turning Around Cybersecurity Through Activism
    As competition climbs and spending slows, security has attracted activists. (FEYE) (IMPV) (FTNT) (CHKP) Full story

  • [By Jayson Derrick]

    It is unclear which company or companies will benefit from this executive order. But that isn’t stopping investors from placing their bets as most cybersecurity stocks were trading higher during Friday’s trading session; at the same time, the Dow Jones Industrial Average and S&P 500 index were trading in the red.

    Shares of Barracuda Networks Inc (NYSE: CUDA) were trading higher by 2.98 percent at $21.77. Shares of Check Point Software Technologies Ltd. (NASDAQ: CHKP) were trading higher by 1.21 percent at $107.00. Shares of FireEye Inc (NASDAQ: FEYE) were trading higher by 0.70 percent at $14.55. Shares of Palo Alto Networks Inc (NYSE: PANW) were trading higher by 0.62 percent at $115.86.

    Related Links:

Top 10 Blue Chip Stocks To Buy Right Now: Charter Communications, Inc.(CHTR)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of OBERNDORF WILLIAM E’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=OBERNDORF+WILLIAM+E

    These are the top 5 holdings of OBERNDORF WILLIAM EWorkiva Inc (WK) – 2,369,384 shares, 43.81% of the total portfolio. Shares added by 38.81%AppFolio Inc (APPF) – 839,797 shares, 26.98% of the total portfolio. Shares reduced by 39.22%Liberty Global PLC (LBTYK) – 289,812 shares, 12% of the total portfolio. Herbalife Ltd (HLF) – 145,000 shares, 9.96% of the total portfolio. Charter Communications Inc (CHTR) – 18,758 shares, 7.25% of the total portfolio.

  • [By Money Morning Staff Reports]

    SoftBank also purchased telecom upstart Sprint Corp. (NYSE: S) in 2013. And it is considering deals with other communications giants, including Charter Communications Inc. (Nasdaq: CHTR) and T-Mobile U.S. Inc. (Nasdaq: TMUS)

  • [By Matt Hogan]

    It has been widely reported that T-Mobile US Inc. (NASDAQ: TMUS) had been in merger talks with Sprint Corp. (NYSE: S), a competitor that is majority owned by Softbank. However, these talks are now on hold as Sprint is negotiating potential deals with two of the largest cable companies in the United States; Comcast Corporation (NASDAQ: CMCSA) and Charter Communications, Inc. (NASDAQ: CHTR). These cable companies are under pressure having lost subscribers due to services like Netflix, Inc. (NASDAQ: NFLX), which recently blew away its second quarter growth estimates.

  • [By Adam Levy]

    Image source: Getty Images.

    It was just a little more than a year ago when Comcast (NASDAQ:CMCSA) was the largest U.S. pay-TV provider. And it wasn’t even close. But after AT&T (NYSE:T) merged with DirecTV, it took over the top spot. Now, AT&T’s rival telecom company, Verizon (NYSE:VZ), is reportedly considering a megamerger of its own with Charter Communications (NASDAQ:CHTR). The move would put the combined company’s total video subscriber count very close to Comcast’s.

    The potential merger points to a big hole in Comcast’s service offerings — its lack of wireless service. If customers can save money by bundling their TV, internet, and wireless bills together with its competitors, Comcast stands to lose customers. But Comcast’s management and investors shouldn’t lose sleep over the possibility that its two biggest competitors offer wireless service.

Top 10 Medical Stocks To Watch Right Now

Varian Medical Systems Inc (NYSE:VAR) files its latest 10-K with SEC for the fiscal year ended on September 30, 2017. Varian Medical Systems Inc is engaged in the healthcare sector. It manufactures medical devices for conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. Varian Medical Systems Inc has a market cap of $10.05 billion; its shares were traded at around $109.46 with a P/E ratio of 40.69 and P/S ratio of 2.98. Varian Medical Systems Inc had annual average EBITDA growth of 9.80% over the past ten years. GuruFocus rated Varian Medical Systems Inc the business predictability rank of 3-star.

For the last quarter Varian Medical Systems Inc reported a revenue of $739.0 million, compared with the revenue of $1.3 billion during the same period a year ago. For the latest fiscal year the company reported a revenue of $2.7 billion, a decrease of 17.1% from the previous year. For the last five years Varian Medical Systems Inc had an average revenue growth rate of 0.1% a year.

Top 10 Medical Stocks To Watch Right Now: The Hackett Group Inc.(HCKT)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, industrial shares were relative laggards, down on the day by about 0.20 percent. Meanwhile, top losers in the sector included The Hackett Group, Inc. (NASDAQ: HCKT), down 22 percent, and PC Tel Inc (NASDAQ: PCTI), down 18 percent.

Top 10 Medical Stocks To Watch Right Now: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    AbbVie Inc. (NYSE: ABBV), Pfizer Inc. (NYSE: PFE), Bristol-Meyers Squibb Co. (NYSE: BMY) and Johnson & Johnson (NYSE: JNJ) combine for over 22 percent of PILL's underlying index.

  • [By Kumar Abhishek]

    The lower number of patient starts and rising competition has been a major worry for Gilead Sciences Inc. Most of the patients with serious Hep-C conditions have already been cured.It is estimated that more than 1 million Hep-C patients have been cured worldwide. And the entry of competitively priced drugs will further dent the growth of this segment. Gilead’s HCV drugs are facing tough competition from Merck (NYSE:MRK), AbbVie (NYSE:ABBV) and Bristol-Myers Squibb (NYSE:BMY). For example, initially, the price difference between Merck’s treatment plan and Gilead’s plan was a whopping $40,000. The rising competition is also impacting the HCV segment’s margins.

  • [By Keith Speights]

    Smart investors will be ready to take advantage of a market pullback, whenever it comes and offers discount prices on great stocks. Three drug stocks appear to be excellent choices to buy on a dip: AbbVie (NYSE:ABBV), Allergan (NYSE:AGN), and Celgene (NASDAQ:CELG). Here’s why.

  • [By Craig Jones]

    Jon Najarian noticed high options volume in the November 205 calls in NVIDIA Corporation (NASDAQ: NVDA) ahead of earnings. He also spoke about unusual activity in AbbVie Inc (NYSE: ABBV). Traders were buying the November 91 calls in the name.

  • [By Todd Campbell]

    AbbVie, Inc.(NYSE:ABBV) is already awaiting a Food and Drug Administration decision on its next-generation successor to Viekira Pak, and that successor is easier to dose than Viekira Pak, can be given over as few as eight weeks, and delivers high cure rates across genotypes.Those advantages could help stabilize AbbVie’s hepatitis C market share, which has declined in the past year.

  • [By Ben Levisohn]

    Today,Coherus BioSciences (CHRS) lost a patent case with AbbVie (ABBV) that would have allowed for a generic version of Humira. Citigroup’s Andrew Baum and Peter Verdult have the details:

Top 10 Medical Stocks To Watch Right Now: Skechers U.S.A., Inc.(SKX)

Advisors’ Opinion:

  • [By Brian Withers] When the number one company in comfort-casual footwear,Skechers (NYSE:SKX) announced earnings last month, the headlines highlighted the first ever $1 billion quarter for the company. It seems investors weren’t impressed, though, as the stock continues to lag behind the market and has missed a nice run up over the past year.

  • [By Matt Hogan]

    Skechers USA Inc (NYSE: SKX) is expected to report earnings on Thursday after the market closes. The footwear company has generally traded lower over the last eight quarters in the face of decelerating revenue growth. The stock had been gaining some momentum in the early part of the year until Susquehanna's Sam Poser downgraded the company to a negative rating on March 29th. Poser warned that domestic wholesale growth would fall short of investor expectations and the stock has since fallen 15 percent.

  • [By Timothy Green]

    Shares of footwear company Skechers (NYSE:SKX) fell 18.6% in 2016, according to data provided byS&P Global Market Intelligence. A slowdown in growth and a string of mixed and negative earnings reports led investors to push down the stock.

  • [By Teresa Rivas]

    Skechers (SKX) is higher on Friday following its fourth-quarter earnings report.

    Getty Images

    Both the companys quarter and guidance were mixed, with higher-than-expected sales, but a downbeat bottom line. The shoe company said that it earned 4 cents a share on revenue that rose 5.8% year over year to $764.3 million. Analysts were expecting a dime per share in earnings on revenue of $726.2 million.

    For the first quarter, the company said it expects to earn between 50 cents and 55 cents a share, below the 66 cents analysts were expecting. However its revenue estimate of $1.05 billion to $1.08 billion was above the $1.05 that analyst are modeling for.

    Wedbushs Christopher Svezia reiterated Neutral rating and $25 price target on the stock, arguing that while hes encouraged by top-line trends, theyre coming at a cost. From his note:

    Shares will likely trade higher (+9% after hours) given the improved revenue outlook and what may have been a low bar on expectations. However, sales growth is not translating into earnings and the inflection continues to move further out, increasing risk should growth not materialize. We are maintaining our NEUTRAL rating and $25 price target or 14x P/E, a 10% discount to historical averages until we see visibility toward an inflection in earnings growth.

    Skechers is up 20% to $27.95 in recent afternoon trading.

  • [By Lee Jackson]

    Skechers USA Inc. (NYSE: SKX) was raised to Buy at a firm called Monness Crespi & Hardt, which put a $30 price target on the shares. Theconsensus price objective is$26.13, and the 52-week range is $18.81 to $34.27. The stock closed Thursday at a$24.05.

  • [By Lisa Levin] Related HTGM Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline HTG Molecular Diagnostics Completes Initial Technical Feasibility Testing with QIAGEN … (GuruFocus)
    Related Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline Zais Group reports Q4 results (Seeking Alpha)
    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares climbed 204.1 percent to $11.95 after surging 83.64 percent on Thursday. HTG Molecular Diagnostics reported a Q4 loss of $0.76 per share on revenue of $1.5 million.
    ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) shares surged 52.6 percent to $3.45. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.
    Global Brokerage Inc (NASDAQ: GLBR) shares jumped 24.3 percent to $2.30.
    Regulus Therapeutics Inc (NASDAQ: RGLS) shares surged 20 percent to $1.50. Regulus Therapeutics’ Chairman bought 500,000 shares at $1.22 per share.
    Rocket Fuel Inc (NASDAQ: FUEL) shares gained 15.6 percent to $5.19.
    Akoustis Technologies Inc (NASDAQ: AKTS) rose 13.3 percent to $10.75 as the company agreed to acquire wafer manufacturing facility for $2.75 million in cash.
    TOP SHIPS Inc (NASDAQ: TOPS) shares gained 12.6 percent to $1.25.
    Inventure Foods Inc (NASDAQ: SNAK) jumped 10.4 percent to $4.46 after the company announced the strategic sale of Fresh Frozen Foods for $23.7 million in cash.
    CymaBay Therapeutics Inc (NASDAQ: CBAY) surged 8.7 percent to $4.14. Cymabay Therapeutics reported a Q4 loss of $0.30 per share.

Top 10 Medical Stocks To Watch Right Now: Beazer Homes USA, Inc.(BZH)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market performed well on Tuesday, responding to steady improvement among many companies as earnings season kicked into high gear. Although political issues are likely to remain in the spotlight for some investors for the foreseeable future, many market participants are looking to economic and business issues in driving their investing decisions. Major market benchmarks finished the day with gains of 0.5% to 1%, but some stocks did much better. Among the best performers on the day were Allegheny Technologies (NYSE:ATI), II-VI (NASDAQ:IIVI), and Beazer Homes (NYSE:BZH). Below, we’ll look more closely at these stocks to tell you why they did so well.

Top 10 Medical Stocks To Watch Right Now: ZAIS Group Holdings, Inc.(ZAIS)

Advisors’ Opinion:

  • [By Lisa Levin] Related HTGM Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline HTG Molecular Diagnostics Completes Initial Technical Feasibility Testing with QIAGEN … (GuruFocus)
    Related Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline Zais Group reports Q4 results (Seeking Alpha)
    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares climbed 204.1 percent to $11.95 after surging 83.64 percent on Thursday. HTG Molecular Diagnostics reported a Q4 loss of $0.76 per share on revenue of $1.5 million.
    ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) shares surged 52.6 percent to $3.45. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.
    Global Brokerage Inc (NASDAQ: GLBR) shares jumped 24.3 percent to $2.30.
    Regulus Therapeutics Inc (NASDAQ: RGLS) shares surged 20 percent to $1.50. Regulus Therapeutics’ Chairman bought 500,000 shares at $1.22 per share.
    Rocket Fuel Inc (NASDAQ: FUEL) shares gained 15.6 percent to $5.19.
    Akoustis Technologies Inc (NASDAQ: AKTS) rose 13.3 percent to $10.75 as the company agreed to acquire wafer manufacturing facility for $2.75 million in cash.
    TOP SHIPS Inc (NASDAQ: TOPS) shares gained 12.6 percent to $1.25.
    Inventure Foods Inc (NASDAQ: SNAK) jumped 10.4 percent to $4.46 after the company announced the strategic sale of Fresh Frozen Foods for $23.7 million in cash.
    CymaBay Therapeutics Inc (NASDAQ: CBAY) surged 8.7 percent to $4.14. Cymabay Therapeutics reported a Q4 loss of $0.30 per share.
  • [By Lisa Levin]

    Shares of ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) got a boost, shooting up 48 percent to $3.35. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.

  • [By Lisa Levin]

    Shares of ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) got a boost, shooting up 42 percent to $3.22. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.

Top 10 Medical Stocks To Watch Right Now: Exelon Corporation(EXC)

Advisors’ Opinion:

  • [By Monica Gerson]

    Exelon Corporation (NYSE: EXC) is expected to report its quarterly earnings at $0.68 per share on revenue of $7.52 billion.

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion.

  • [By Casey Wilson]

    That brings us to General Electric Co. (NYSE: GE). The 125-year-old American mainstay signed a deal with Exelon Corp. (NYSE: EXC) last fall for the energy utility to use its own predictive analytics software, fittingly dubbed “Predix.”

  • [By Lisa Levin]

    Utilities shares climbed by 0.64 percent in trading on Friday. Meanwhile, top gainers in the sector included Exelon Corporation (NYSE: EXC), and FirstEnergy Corp. (NYSE: FE).

Top 10 Medical Stocks To Watch Right Now: GAIN Capital Holdings, Inc.(GCAP)

Advisors’ Opinion:

  • [By Lisa Levin]

    FXCM Inc (NASDAQ: FXCM) shares dropped 53 percent to $3.24 after the company announced regulatory settlements with NFA and CFTC against its U.S. subsidiary, Forex Capital Markets LLC. Gain Capital Holdings Inc (NYSE: GCAP) agreed to acquire the client base of FXCM's U.S. operations after FXCM reported that it will be withdrawing from U.S. business.

  • [By Lisa Levin]

    In trading on Friday, financial shares fell 0.16 percent. Meanwhile, top losers in the sector included Federated National Holding Co (NASDAQ: FNHC), down 11 percent, and Gain Capital Holdings Inc (NYSE: GCAP), down 7 percent.

Top 10 Medical Stocks To Watch Right Now: Celestica, Inc.(CLS)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of small cap Sanmina Corp (NASDAQ: SANM), a previous Elite Opportunity Pro (EOP) newsletter suggestion as the next breakout stock, andmid cap Flextronics International being bigger winners compared with the also good performance of mid cap Jabil Circuit, Inc (NYSE: JBL) and small cap Celestica Inc (NYSE: CLS):

  • [By Peter Graham]

    A long term performance chart shows shares of mid caps Jabil Circuit and Flextronics International Ltd (NASDAQ: FLEX) along with small capCelestica Inc (NYSE: CLS) and Sanmina Corp (NASDAQ: SANM), a previous Elite Opportunity Pro (EOP) newslettersuggestion as the next breakout stock, all performing well recently as the tech stocks they supply outperform:

Top 10 Medical Stocks To Watch Right Now: Guess?, Inc.(GES)

Advisors’ Opinion:

  • [By Paul Ausick]

    Guess Inc. (NYSE: GES) posted a new 52-week low of $10.33 on Thursday, down about 15.5% compared with Wednesday’s closing price of $12.23. The stock’s 52-week high is $19.45. Volume was more than 7 times the daily average of around 1.3 million shares. The apparel maker missed quarterly estimates and the outlook for improvement is murky at best.

  • [By Peter Graham]

    Small cap apparel retailerGuess?, Inc (NYSE: GES) reportedearnings for Q3 Fiscal 2018 (ended October28, 2017) after the market closed on Wednesday with results mixed on anearnings beat, but weaker than anticipated revenue due to asharper decline than expected in North American year-over-year sales.Total net revenue increased 3.3% or 0.6% in constant currencyto $554.1 million, compared to $536.3 million in the prior-year quarter as:

  • [By Lisa Levin]

    Guess?, Inc. (NYSE: GES) was down, falling around 13 percent to $15.65. Guess? reported in-line earnings for its third quarter, while sales missed estimates. U.S. comps were down 10 percent.

Top 10 Medical Stocks To Watch Right Now: Aerohive Networks, Inc.(HIVE)

Advisors’ Opinion:

  • [By Monica Gerson]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Citigroup Inc (NYSE: C) to report quarterly earnings at $1.16 per share on revenue of $17.34 billion before the opening bell. Citigroup shares rose 0.47 percent to $48.70 in after-hours trading.
    HP Inc (NYSE: HPQ) disclosed that it would be implementing a restructuring plan that would likely result in the firing of 3,000 to 4,000 employees, annual savings of $200 million to $300 million, and a charge of $350 million to $500 million. Management also announced a 7 percent surge in the stock’s dividend and an additional $3 million share repurchase program. The company issued its outlook for fiscal 2017, guiding for EPS of $1.55 to $1.65, mostly below the Street’s consensus of $1.64. HP shares fell 1.32 percent to $14.95 in the after-hours trading session.
    Analysts are expecting JPMorgan Chase & Co. (NYSE: JPM) to have earned $1.39 per share on revenue of $23.99 billion in the latest quarter. JPMorgan will release earnings before the markets open. JPMorgan shares gained 0.37 perecent to $67.99 in after-hours trading.
    Aerohive Networks Inc (NYSE: HIVE) reported weak preliminary results for its third quarter. The company said it expects a net loss of $(0.06) to $(0.07) per share, versus consensus at $(0.04) per share. Revenue guidance of $40 million also fell short of expectations for almost $48 million. Aerohive shares dropped 18.29 percent to $4.60 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin]

    Shares of Aerohive Networks Inc (NYSE: HIVE) were down 33 percent to $3.10. Aerohive Networks reported a Q2 loss of $3.9 million on revenue of $42.3 million, and disclosed that it has extended its $10 million buyback plan.

Top 10 Casino Stocks To Buy Right Now

Related NLNK Mid-Day Market Update: Bob Evans Farms Rises On Acquisition News; Mediwound Shares Plunge Mid-Morning Market Update: Markets Edge Higher; AutoZone Earnings Top Expectations
Related WYNN Najarian Brothers See Unusual Options Activity In AbbVie And Wynn Resorts Wynn Resorts Reaches Highest Level Since March 2015 Newly Independent Casino Operator Set To Open New Macau Resort (Investor’s Business Daily)

Benzinga Pro provides its subscribers with real-time alerts of potentially market-moving options activity.

Here's a recap of the options alerts from Friday, September 22, 2017. All time stamps are in Eastern Time.

11:45:04 am: NLNK NewLink Genetics Shares Up ~$0.40 Over Last Few Mins. Amid Notable Option Activity: Nov. $16 Calls At The Ask Showing Volume Of 1K vs Open Interest of 100 Contracts

11:43:19 am: FIT Notable Option Activity In Fitbit: Oct. $6.50 Calls At The Bid Showing Volume Of 3K vs Open Interest Of 51

Top 10 Casino Stocks To Buy Right Now: Pound/Rand(PX)

Advisors’ Opinion:

  • [By Ben Levisohn]

    The last twelve months haven’t been kind to Praxair (PX) and Air Products & Chemicals (APD), but UBS analyst John Roberts and team argue that’s about to change, as they upgrade their shares to Buy from Neutral arguing that their earnings can withstand a slowing global economy:

    In our view, the two stocks are more alike than different. NTM P/Es are within ~0.5 pts of each other. Both stocks have declined ~20% from their historical highs the largest corrections in 20+ years aside from the financial crisis…

    Industrial gas stocks have normally grown through changes in FX, oil & China demand within normal historical ranges. And investor concerns around China forAir Products & Chemicals may still prove much bigger than reality. Nevertheless, the combination of FX & oil sector impacts on Praxair, and FX & China issues for Air Products & Chemicals, have been much larger than previously seen. With oil already down, the dollar already appreciated, & China concerns already heightened we believe forward basis would appear to carry only normal risks (& lower if FX & oil are mean-reverting, which some theories support).

    Normal high single digit EPS growth projected for both in 2017 vs 2016: Four large firms serve 70%+ of the global merchant gas market, and price normally contributes ~2% to growth. Customer older captive units being outsourced contributes another 2%. Secular drivers for oxygen include energy savings (i.e. O2 burns more efficiently than air), life sciences (healthcare & microbial processes) nitrogen secular drivers include increasing purity requirements (food freezing & semiconductors). Topline growth ~2x global GDP more normal, with EPS growth ~2x sales growth due to high fixed costs (key variable costs are inexpensive air & power).

    Financial crisis demand drop was only a few %, in line with global GDP drop Most chemicals volumes dropped 10%+ (some 40%

Top 10 Casino Stocks To Buy Right Now: MBIA, Inc.(MBI)

Advisors’ Opinion:

  • [By Dan Caplinger]

    But some stocks managed to buck the trend and give investors more upbeat outlooks for their prospects. SandRidge Energy (NYSE: SD), MBIA (NYSE:MBI), and LivePerson (NASDAQ:LPSN) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

Top 10 Casino Stocks To Buy Right Now: QuickLogic Corporation(QUIK)

Advisors’ Opinion:

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston
  • [By Alex McGuire]

    These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…

    Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%

    As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.

  • [By Lisa Levin]

    QuickLogic Corporation (NASDAQ: QUIK) was down, falling around 10 percent to $2.10. QuickLogic reported a $15 million share offering.

    Commodities

Top 10 Casino Stocks To Buy Right Now: Vitality Biopharma (VBIO)

Advisors’ Opinion:

  • [By James E. Brumley]

    Investors who were looking to learn a little more about up-and-coming drug development company Vitality Biopharma Inc (OTCMKTS:VBIO) may want to mark December 8th on their calendar…. if they’re going to be in the Los Angeles area that day anyway. The company will be making a presentation that day, at the annual LD Micro Main Event. Interested and approved investors can attend the VBIO presentation by registering beforehand with LD Micro.

    Vitality Biopharma has found a way to make cannabinoid-based pharmaceuticals without the usual downside of cannabinoids. Namely, Vitality Biopharma’s version of cannabinoids are non-psychotropic, meaning larger, more effective dosing is possible without the ‘high’. It’s this little detail that takes cannabinoid medicine — already the most compelling frontier in the world of pharma — to the next level. There’s a reason some people think the cannabinoid market could be worth $20 billion by 2020.

    The idea was significantly advanced in early November. In eight of the nine states voters were asked about legalization of marijuana (for one reason or another), voters said yes….. four for recreational use, and four for medical use. In eight of those nine states, the measures passed. Marijuana is legal in more than half the United States now, and we’re en route to a decided majority in the foreseeable future.

    VBIO didn’t necessarily need a sweeping victory at the ballot box, but each time marijuana wins, it seems to advance the discussion of the power of cannabinoids as medicine.

    Investors will be able to learn more about Vitality Biopharma’s work in that arena on Thursday of this week. On that day — 8 AM PST / 11 AM EST — at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Robert Brooke, CEO of Vitality Biopharma, will be making a presentation as well as meeting with current and prospective investors.

    LD Micro was founded in 2006 with the sole purpose of being an independent resource in t

  • [By James E. Brumley]

    Are you an investor interested in learning more about Vitality Biopharma Inc (OTCMKTS:VBIO)? Or, are you looking to take your first look at VBIO? A SeeThruEquity research report posted in August not only has you covered, it underscores all of its hidden bullishness. The report also explains a very impressive target price for Vitality Biopharma shares. In short, the research outfit now believes the stock will see $2.00 per share sooner than later, based on its pipeline and potential market penetration. That’s 38% higher than its current value.

  • [By Matthew Briar]

    Back in September, Vitality Biopharma Inc (OTCMKTS:VBIO) CEO Robert Brooke officially announced his company would be entering the painkiller market, specifically taking aim at the development of an alternative to opioids. His specific words? “Opiates are one of the key classes of drugs we’re seeking to replace, or to make far less necessary, as our proprietary cannabosides could provide a potent alternative form of pain relief and help avoid, or greatly reduce, the use of opiates for the treatment of many conditions…”

  • [By Jim Robertson]

    That’s why its worth pointing out that just yesterday, small cap cannabinoid prodrug pharmaceutical stock Vitality Biopharma, Inc. (OTCQB: VBIO) announced the appointment of Tracy Rockney, J.D. to the position of Senior Regulatory Advisor. In addition to being the Co-Founder & Chief Operating Officer of OneSource Regulatory, a regulatory consulting firm, Rockney was previously:

  • [By Phil Saunders]

    Vitality Biopharma, Inc. (OTCBB: VBIO) recent ascent as a strong small cap player in Cannabis pharma, is part of a boom in Cannabis-based pharmaceuticals making announcements about unique and innovative delivery systems being tested for such ailments as Epilepsy, Multiple Sclerosis, and Crohns disease. But it is important to understand how the industry is evolving in the United States and Canada and what that might mean when realizing valuation and the evolution of government policies which still vary from jurisdiction to jurisdiction, making access to Cannabis and the pricing model still a big question moving forward.

  • [By Jim Robertson]

    Yesterday, small cap cannabinoid prodrug pharmaceutical stock Vitality Biopharma, Inc. (OTCQB: VBIO) announcedthe filing of an international patent application that describes compounds discovered to be effective for neural repair treatments. The underlying patent rights were assigned to Vitality Biopharma in March 2016 and are based on work performed by the Myelin Repair Foundation (MRF) -a non-profit disease research organization that was dedicated to developing regenerative therapies for multiple sclerosis.

Top 10 Casino Stocks To Buy Right Now: China Jo-Jo Drugstores, Inc.(CJJD)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested small cap Chinese retail pharmacy stock China Jo-Jo Drugstores (NASDAQ: CJJD) as a bullish long trade:

Top 10 Casino Stocks To Buy Right Now: Coherent, Inc.(COHR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Rofin-Sinar Technologies (NASDAQ: RSTI) got a boost, shooting up 37 percent to $31.50 as Coherent, Inc. (NASDAQ: COHR) announced its plans to buy Rofin-Sinar Technologies Inc in a deal valued at around $942 million.

Top 10 Casino Stocks To Buy Right Now: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By George Budwell]

    Keeping this theme in mind, I think the Dividend Aristocrats AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Medtronic plc (NYSE:MDT) are three outstanding stocks to steady any portfolio during these uncertain times. Here’s why.

  • [By Kumar Abhishek]

    The lower number of patient starts and rising competition has been a major worry for Gilead Sciences Inc. Most of the patients with serious Hep-C conditions have already been cured.It is estimated that more than 1 million Hep-C patients have been cured worldwide. And the entry of competitively priced drugs will further dent the growth of this segment. Gilead’s HCV drugs are facing tough competition from Merck (NYSE:MRK), AbbVie (NYSE:ABBV) and Bristol-Myers Squibb (NYSE:BMY). For example, initially, the price difference between Merck’s treatment plan and Gilead’s plan was a whopping $40,000. The rising competition is also impacting the HCV segment’s margins.

  • [By J.B. Maverick]

     The pharmaceutical and health care sectors are generally less vulnerable to volatile and cyclical market moves, and may be one of the safer bets in 2016. Major drug manufacturer AbbVie, Inc. (NYSE: ABBV) has performed well for investors, and there are plenty of reasons to believe it will continue to do so. It is difficult to find a stock that shows a return on equity (ROE) of 59.3%, more than double the industry average of 23.3%. In addition, the stock’s dividend yield of 3.76% is well above the S&P 500 average, and the company has stated its firm commitment to return income to investors with a growing dividend payout. With successful drugs such as Humira and Imbruvica, and promising new ones in the company’s development pipeline, AbbVie has experienced revenue growth from $14 billion to $23 billion since 2009, and analysts project earnings per share (EPS) in the neighborhood of $5 for 2016, which represents an increase of 17%.

  • [By Javier Hasse]

    8:05:11 am: ABBV WYNN Najarian Brothers See Unusual Options Activity In AbbVie And Wynn Resorts. Jon Najarian spoke on CNBC's "Fast Money Halftime Report" about unusually high options activity in AbbVie Inc (NYSE: ABBV). He said that options traders bought aggressively the October 91 calls. He decided to follow the trade and he is planning to hold it…

  • [By Alex McGuire]

    Meanwhile, the 61 healthcare stocks in the S&P 500 – such as AbbVie Inc. (NYSE: ABBV) and Humana Inc. (NYSE: HUM) – offer an average yield of 1.75%.

Top 10 Casino Stocks To Buy Right Now: Constellation Brands Inc(STZ)

Advisors’ Opinion:

  • [By Rich Duprey]

    It’s not all bad news, as brewers such as Lagunitas and Dogfish Head, among others, were up by double-digit percentages. Constellation Brands (NYSE:STZ) also surged, and though much of that increase might be attributable to its imported Corona brands, it also has its Ballast Point craft brand to thank, as it’s been living up to its reputation as the fastest-growing craft beer.

  • [By WWW.THESTREET.COM]

    In his second “Executive Decision” segment, Cramer also checked in with Rob Sands, president and CEO of Constellation Brands (STZ) , the wine and spirits maker that just posted a 24-cents-a-share earnings beat on inline revenues, but saw shares fall 7% on fears Donald Trump may impose an import tax on the company’s products, notably Corona, which hails from Mexico.

  • [By Ben Levisohn]

    Constellation Brands (STZ) has rallied 4.7% to $169 after beating earnings forecasts and offering optimistic guidance.

    Greenbrier Cos. (GBX) has advanced 2.1% to $48.25 after getting upgraded to Buy from Neutral at BofA Merrill Lynch.

  • [By Casey Wilson]

    Constellation Brands Inc. (NYSE: STZ), which owns popular beer brands like Corona, is the latest company to realize the profit potential of the legal marijuana industry.

Top 10 Casino Stocks To Buy Right Now: Internationa Flavors & Fragrances, Inc.(IFF)

Advisors’ Opinion:

  • [By Lee Jackson]

    International Flavors & Fragrances Inc. (NYSE: IFF) is yet another company that hit our screens witha 10% institutional owner buying stock twice last week. Winder Investment purchased a total of 70,000 shares. At $128.38per share, the total for the trade was a solid $9 million. Later in the week the company stepped in again and bought another100,000 shares at prices between $129.47 and 132.20 apiece. The total for that buy was posted at $13 million. The shares closed trading last Friday at $133.19, so some timely buys for sure. The 52-week trading range is $112.91 to $143.64. The consensus price target is $131.40.

Top 10 Casino Stocks To Buy Right Now: IPG Photonics Corporation(IPGP)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Monday began on a down note for the stock market, as the Dow Jones Industrials fell back down below the 20,000 level. Major market benchmarks finished with losses of 0.6% to 0.8%, and some market commentators attributed the declines to nervousness about the Trump administration’s actions to clamp down on immigration. Others noted that the latest reading of U.S. economic growth showed a 1.9% rise in gross domestic product for the fourth quarter, finishing the year with an overall GDP increase of just 1.6%, down a full percentage point from 2015’s growth. Despite the overall sullen mood in the market, some stocks gained ground, and GoPro (NASDAQ:GPRO), Movado Group (NYSE:MOV), and IPG Photonics (NASDAQ:IPGP) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

Top 10 Value Stocks To Watch For 2018

Workers install a 25-foot tall fermenter at Brooklyn Brewery on October 23, 2012 in the Brooklyn borough of New York City. (Photo by Mario Tama/Getty Images)

This commentary relates to a profile of New Belgium Brewery in the July 27 Forbes.

Craft beer–how quaint, how cute! But don’t fall in love with an investment because you love the product. Craft Brew Alliance (BREW) is an assortment of artisanal beermakers from Oregon, Hawaii, New Hampshire and elsewhere. But a fair amount of its brewing and most of its distribution is handled by Anheuser-Busch InBev (BUD), the Budweiser outfit.

In this crowded business, where freshness and economies of scale matter, smallness does not confer profits. Craft Brew’s enterprise value runs to 29 times its plausible 2017 net before interest, tax and depreciation; the ratio for AB InBev is more like 18. The latter is a better buy.

Top 10 Value Stocks To Watch For 2018: Guidewire Software, Inc.(GWRE)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Ebix Inc actually performing well since the end of 2014 while mid cap peer Guidewire Software Inc (NYSE: GWRE) has been outperforming over a longer period of time and small cap Benefitfocus Inc (NASDAQ: BNFT) has underperformed:

  • [By Monica Gerson]

    Guidewire Software Inc (NYSE: GWRE) is estimated to post its quarterly earnings at $0.06 per share on revenue of $92.43 million.

    Analogic Corporation (NASDAQ: ALOG) is projected to post its quarterly earnings at $0.88 per share on revenue of $127.30 million.

Top 10 Value Stocks To Watch For 2018: Emerald Health Therapeutics, Inc. (TBQBF)

Advisors’ Opinion:

  • [By Javier Hasse]

    Emerald Health Therapeutics Inc (OTC: TBQBF) raised C$13.8 million ($10.5 million) under a bought deal financing.

    “The money will be primarily used for facility expansion."

    The Green Solution received a $7.5 million loan facility from iAnthus Capital Holdings Inc (OTC: ITHUF).

Top 10 Value Stocks To Watch For 2018: Entercom Communications Corporation(ETM)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap radio broadcasting stock Entercom Communications Corp (NYSE: ETM), a potential peer of Emmis Communications Corporation (NASDAQ: EMMS), Saga Communications (NYSEAMERICAN: SGA) and troubled Cumulus Media (NASDAQ: CMLS), is the tenth most shorted stock on the NYSE with short interest of 45.06% according to Highshortnterest.com.

Top 10 Value Stocks To Watch For 2018: Ritchie Bros. Auctioneers Incorporated(RBA)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Raymond James has downgraded Ritchie Bros. Auctioneers Inc (USA) (NYSE: RBA) common stock to Market Perform

    Loop Capital's Betsy Van Hees sees storage, networking, and connectivity as the 3 reasons why Marvell Technology Group Ltd. (NASDAQ: MRVL) will return to top-Line growth. She reiterated her Buy rating and $18 price target. 

Top 10 Value Stocks To Watch For 2018: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By Jim Robertson]

    That’s why its worth pointing out that just yesterday, small cap cannabinoid prodrug pharmaceutical stock Vitality Biopharma, Inc. (OTCQB: VBIO) announced the appointment of Tracy Rockney, J.D. to the position of Senior Regulatory Advisor. In addition to being the Co-Founder & Chief Operating Officer of OneSource Regulatory, a regulatory consulting firm, Rockney was previously:

    From May 2010 to May 2015, she was the VP, Regulatory Affairs at AbbVie Inc (NYSE: ABBV) leading the executive functions related to regulatory policy and intelligence. From August 1993 to January 2005, she held positions of increasing responsibility with Pfizer Inc (NYSE: PFE), formerly Wyeth.  From January 2005 to April 2010, she held positions with Shire PLC (NASDAQ: SHPG), including serving as Senior Director, Regulatory Affairs. This included responsibilities as Therapeutic Area Head for Shire’s Gastrointestinal Business Unit, Regulatory Advertising & Promotion and CMC. Rockney led the regulatory team and negotiations with the FDA for LIALDA which are part of the drug class of aminosalicylates that are now part of the clinical standard-of-care for treating inflammatory bowel disease. LIALDA™ was found to be effective in Phase 3 trials for inducing remission of active mild-to-moderate ulcerative colitis after eight weeks of treatment. LIALDA™ (also now marketed as Mezavant®) had 2016 U.S. sales of $714 million – up 16% relative to 2015 sales.

    Rockney’s work for Shire is of particular interest to Vitality Biopharma which has developed a new class of cannabinoid prodrugs (medications or compounds that, after administration, are converted within the body into a pharmacologically active drug), known as cannabosides, which upon ingestion can enable the selective delivery of THC and cannabidiol (CBD) to the gastrointestinal tract. Cannabosides could provide therapeutic benefits for infl

  • [By Todd Campbell]

    AbbVie, Inc.(NYSE:ABBV) is already awaiting a Food and Drug Administration decision on its next-generation successor to Viekira Pak, and that successor is easier to dose than Viekira Pak, can be given over as few as eight weeks, and delivers high cure rates across genotypes.Those advantages could help stabilize AbbVie’s hepatitis C market share, which has declined in the past year.

  • [By Ben Levisohn]

    Today,Coherus BioSciences (CHRS) lost a patent case with AbbVie (ABBV) that would have allowed for a generic version of Humira. Citigroup’s Andrew Baum and Peter Verdult have the details:

  • [By Alex McGuire]

    Meanwhile, the 61 healthcare stocks in the S&P 500 – such as AbbVie Inc. (NYSE: ABBV) and Humana Inc. (NYSE: HUM) – offer an average yield of 1.75%.

  • [By Jim Crumly]

    Just as the body’s normal stem cells renew and sustain organs and tissue, cancer stem cells do the same for tumors. Large cap drugmaker AbbVie (NYSE:ABBV) is taking the lead in developing drugs to go after cancer stem cells, and long-term investors could enjoy the payoff.

Top 10 Value Stocks To Watch For 2018: Aethlon Medical, Inc.(AEMD)

Advisors’ Opinion:

  • [By Monica Gerson]

     

    General Mills, Inc. (NYSE: GIS) is expected to report its quarterly earnings at $0.60 per share on revenue of $3.86 billion.
    Pier 1 Imports Inc (NYSE: PIR) is projected to post a quarterly loss at $0.05 per share on revenue of $420.05 million.
    Acuity Brands, Inc. (NYSE: AYI) is estimated to report its quarterly earnings at $2.03 per share on revenue of $847.79 million.
    Monsanto Company (NYSE: MON) is projected to report its quarterly earnings at $2.40 per share on revenue of $4.49 billion.
    Worthington Industries, Inc. (NYSE: WOR) is expected to report its quarterly earnings at $0.64 per share on revenue of $692.48 million.
    Progress Software Corporation (NASDAQ: PRGS) is projected to post its quarterly earnings at $0.29 per share on revenue of $94.64 million.
    UniFirst Corp (NYSE: UNF) is estimated to report its quarterly earnings at $1.34 per share on revenue of $366.28 million.
    Exfo Inc (NASDAQ: EXFO) is expected to post its quarterly earnings at $0.06 per share on revenue of $60.87 million.
    OMNOVA Solutions Inc. (NYSE: OMN) is projected to report its quarterly earnings at $0.14 per share on revenue of $205.40 million.
    8Point3 Energy Partners LP (NASDAQ: CAFD) is estimated to post a quarterly loss at $0.01 per share on revenue of $11.60 million.
    Park Electrochemical Corp. (NYSE: PKE) is expected to report its quarterly earnings at $0.22 per share on revenue of $35.30 million.
    Xplore Technologies Corp. (NASDAQ: XPLR) is projected to post its quarterly earnings at $0.01 per share on revenue of $24.00 million.
    Investors Real Estate Trust (NYSE: IRET) is expected to post its quarterly earnings at $0.14 per share on revenue of $56.87 million.
    Tel-Instrument Electronics Corp. (NYSE: TIK) is estimated to post earnings for the latest quarter.
    Aethlon Medical, Inc. (NASDAQ: AEMD) is expected to post a quarterly loss at $0.20 per share.
    Ossen Innovation Co Ltd (ADR) (NASDAQ: OSN) is projected to post ea

Top 10 Value Stocks To Watch For 2018: SM Energy Company(SM)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Wednesday, the energy sector proved to be a source of strength for the market. Leading the sector was strength from SM Energy Co (NYSE: SM) and W&T Offshore, Inc. (NYSE: WTI).

  • [By Lisa Levin]

    Energy sector was the top gainer in the US market on Monday. Top gainers in the sector included Helix Energy Solutions Group Inc (NYSE: HLX), SM Energy Co (NYSE: SM), and Ecopetrol SA (ADR) (NYSE: EC).

  • [By Lisa Levin]

    Energy sector was the top gainer in the US market on Friday. Top gainers in the sector included Superior Energy Services, Inc. (NYSE: SPN), Panhandle Oil and Gas Inc. (NYSE: PHX), and SM Energy Co (NYSE: SM).

Top 10 Value Stocks To Watch For 2018: Tel-Instrument Electronics Corp.(TIK)

Advisors’ Opinion:

  • [By Monica Gerson]

     

    General Mills, Inc. (NYSE: GIS) is expected to report its quarterly earnings at $0.60 per share on revenue of $3.86 billion.
    Pier 1 Imports Inc (NYSE: PIR) is projected to post a quarterly loss at $0.05 per share on revenue of $420.05 million.
    Acuity Brands, Inc. (NYSE: AYI) is estimated to report its quarterly earnings at $2.03 per share on revenue of $847.79 million.
    Monsanto Company (NYSE: MON) is projected to report its quarterly earnings at $2.40 per share on revenue of $4.49 billion.
    Worthington Industries, Inc. (NYSE: WOR) is expected to report its quarterly earnings at $0.64 per share on revenue of $692.48 million.
    Progress Software Corporation (NASDAQ: PRGS) is projected to post its quarterly earnings at $0.29 per share on revenue of $94.64 million.
    UniFirst Corp (NYSE: UNF) is estimated to report its quarterly earnings at $1.34 per share on revenue of $366.28 million.
    Exfo Inc (NASDAQ: EXFO) is expected to post its quarterly earnings at $0.06 per share on revenue of $60.87 million.
    OMNOVA Solutions Inc. (NYSE: OMN) is projected to report its quarterly earnings at $0.14 per share on revenue of $205.40 million.
    8Point3 Energy Partners LP (NASDAQ: CAFD) is estimated to post a quarterly loss at $0.01 per share on revenue of $11.60 million.
    Park Electrochemical Corp. (NYSE: PKE) is expected to report its quarterly earnings at $0.22 per share on revenue of $35.30 million.
    Xplore Technologies Corp. (NASDAQ: XPLR) is projected to post its quarterly earnings at $0.01 per share on revenue of $24.00 million.
    Investors Real Estate Trust (NYSE: IRET) is expected to post its quarterly earnings at $0.14 per share on revenue of $56.87 million.
    Tel-Instrument Electronics Corp. (NYSE: TIK) is estimated to post earnings for the latest quarter.
    Aethlon Medical, Inc. (NASDAQ: AEMD) is expected to post a quarterly loss at $0.20 per share.
    Ossen Innovation Co Ltd (ADR) (NASDAQ: OSN) is projected to post ea

Top 10 Value Stocks To Watch For 2018: Porter Bancorp Inc.(PBIB)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of PATRIOT FINANCIAL PARTNERS GP, LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=PATRIOT+FINANCIAL+PARTNERS+GP%2C+LP

    These are the top 5 holdings of PATRIOT FINANCIAL PARTNERS GP, LPBanc of California Inc (BANC) – 2,850,564 shares, 27.82% of the total portfolio. Guaranty Bancorp (GBNK) – 1,891,767 shares, 23.36% of the total portfolio. Shares reduced by 19.22%Meta Financial Group Inc (CASH) – 347,069 shares, 14.02% of the total portfolio. Sterling Bancorp (STL) – 1,048,980 shares, 11.07% of the total portfolio. Shares reduced by 16.01%MBT Financial Corp (MBTF) – 2,060,302 sha

Top 10 Value Stocks To Watch For 2018: United States Cellular Corporation(USM)

Advisors’ Opinion:

  • [By Monica Gerson]

    United States Cellular Corp (NYSE: USM) is projected to report its quarterly earnings at $0.26 per share on revenue of $975.54 million.

    Koppers Holdings Inc. (NYSE: KOP) is estimated to report its quarterly earnings at $0.09 per share on revenue of $364.50 million.

  • [By Lisa Levin]

    In trading on Monday, telecommunications services shares fell by 0.77 percent. Meanwhile, top losers in the sector included United States Cellular Corp (NYSE: USM), down 5 percent, and B Communications Ltd (NASDAQ: BCOM), down 5 percent.

Top High Tech Stocks For 2018

What happened

Shares of dry bulk ocean shipper Diana Shipping (NYSE:DSX) surged 37% in the first month of the new year, rising from $3.02 at the start of January to end at $4.14 at its close. As the calendar moves into February, however, Diana’s shares are moving into reverse — down more than 2% since the month began.

So what

Why this is happening is not immediately clear, although there was a lot happening elsewhere in the shipping sector last month — everything from a buyout offer for tanker company DHT Holdings (NYSE:DHT) to a convoluted restructuring ongoing at DryShips (NASDAQ:DRYS). Meanwhile at Diana, the main news has been of multiple new time charter contracts for its vessels being signed last month, alongside the extension of multiple other existing contracts — signings that have continued into February. Clearly, Diana doesn’t seem to be having trouble finding customers. On the other hand, the rates the company is getting on its charters may not be the best.

Dry-bulk shipping of iron ore to shore makes up a big part of Diana’s business. Image source: Getty Images.

Top High Tech Stocks For 2018: GenMark Diagnostics, Inc.(GNMK)

Advisors’ Opinion:

  • [By Lisa Levin]

    GenMark Diagnostics, Inc (NASDAQ: GNMK) shares shot up 20 percent to $10.54. Cowen & Co. upgraded GenMark Diagnostics from Market Perform to Outperform.

Top High Tech Stocks For 2018: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Today,Coherus BioSciences (CHRS) lost a patent case with AbbVie (ABBV) that would have allowed for a generic version of Humira. Citigroup’s Andrew Baum and Peter Verdult have the details:

  • [By WWW.KIPLINGER.COM]

    AbbVie Inc. (ABBV) stock is having a market-beating year with its gain of more than 7%, and the dividend only pads that lead. Slow-but-steady growth is a basic part of the equation.

  • [By Keith Speights, Brian Stoffel, and George Budwell]

    Healthcare is changing rapidly. Which companies will emerge as the huge winners with these major changes? We asked three of our healthcare contributors to weigh in on the subject. Here’s whyAbbVie (NYSE:ABBV),Alphabet (NASDAQ:GOOGL) (NASDAQ:GOOG), Johnson & Johnson (NYSE:JNJ), and Veeva Systems (NYSE:VEEV) could represent bold bets on the future of healthcare.

  • [By Keith Speights]

    I recently bought shares of seven different companies. One of those companies was AbbVie (NYSE:ABBV). I had different reasons for buying each of the stocks. Some were in sectors in which I didn’t already have much exposure in my portfolio. That wasn’t the case with AbbVie, though. I already owned quite a few healthcare stocks and exchange-traded funds (ETFs).

  • [By J.B. Maverick]

     The pharmaceutical and health care sectors are generally less vulnerable to volatile and cyclical market moves, and may be one of the safer bets in 2016. Major drug manufacturer AbbVie, Inc. (NYSE: ABBV) has performed well for investors, and there are plenty of reasons to believe it will continue to do so. It is difficult to find a stock that shows a return on equity (ROE) of 59.3%, more than double the industry average of 23.3%. In addition, the stock’s dividend yield of 3.76% is well above the S&P 500 average, and the company has stated its firm commitment to return income to investors with a growing dividend payout. With successful drugs such as Humira and Imbruvica, and promising new ones in the company’s development pipeline, AbbVie has experienced revenue growth from $14 billion to $23 billion since 2009, and analysts project earnings per share (EPS) in the neighborhood of $5 for 2016, which represents an increase of 17%.

Top High Tech Stocks For 2018: Tesla Motors, Inc.(TSLA)

Advisors’ Opinion:

  • [By Travis Hoium]

    Panasonic is coming to the rescue of SolarCity’s Silevo solar manufacturing plant, agreeing to invest $256 million in the facility. Tesla (NASDAQ:TSLA) made the investment contingent on its SolarCity acquisition going through; now that the companies are combined, Panasonic is being brought in to help with solar.

  • [By Daniel Sparks]

    In Tesla’s (NASDAQ:TSLA) fourth-quarter shareholder letter, management understandably refrained from providing guidance beyond the first half of 2017. Given that the second half of the year is expected to include the unpredictable production ramp of Tesla’s upcoming higher-volume Model 3, guidance for such an uncertain outcome could do more harm than good for investors.

  • [By Harshal Patel]

    There is a lot of uncertainty surrounding Tesla Motors Inc(NSDQ:TSLA)today. Will the company be able to produce enough Model 3sedans to meet investor expectations? Will the merger with SolarCity cause debt payments to become too high? Will General Motors, with the electric Bolt, win the electric vehicle market? Another uncertainty, I would add is how will a Trump Administration effect Tesla’s profitability?

  • [By Kumar Abhishek]

    Tesla (NSDQ:TSLA) stock has declined by 20% YTD, massively underperforming the market. But while investors are reluctant to invest in the stock, Tesla has been one of the favorite stocks of short traders for some time now. In the latest fortnight, the short interest in TSLA stock jumped by 13% to35.68 million, a massive 32% of the float, with days to cover increasing from 6 days to 8 days. Since August, short interest has jumped by almost 35%. With days to cover rising to 8 days, a strong positive news may lead to a short squeeze. But is there any positive news around the corner for Tesla stock? One source could be tomorrow’s “tech summit” with the President-Elect to which Mr. Musk has been invited.

  • [By Kumar Abhishek]

    After a strong bull run beginning December last year, which saw shares of Tesla Inc (NASDAQ:TSLA) gain more than 50%, Tesla stock is on a steep decline. Tesla stock has fallen more than 12% since the earnings. Tesla Inc missed on its earnings, however, the miss was not the main reason behind the fall in TSLA stock. Tesla’s earnings were followed by negative commentary and multiple price target cuts from analysts spooked the market. Tesla’s rating was recently cut by Goldman Sachs which downgraded the stock from hold to sell. As the image below shows, the spate of negative commentary from analysts has led to astrong rise in bearish sentiment.